ABBADESSA, Salvatore
 Distribuzione geografica
Continente #
EU - Europa 737
NA - Nord America 484
AS - Asia 102
Totale 1.323
Nazione #
US - Stati Uniti d'America 482
IT - Italia 287
IE - Irlanda 142
CN - Cina 74
FR - Francia 63
DE - Germania 58
GB - Regno Unito 56
UA - Ucraina 55
SE - Svezia 28
TR - Turchia 24
FI - Finlandia 23
BE - Belgio 12
GR - Grecia 9
CH - Svizzera 2
MX - Messico 2
NL - Olanda 2
IN - India 1
JP - Giappone 1
PK - Pakistan 1
TW - Taiwan 1
Totale 1.323
Città #
Dublin 142
Chandler 91
Jacksonville 83
Ann Arbor 61
Rome 29
Caserta 23
Nanjing 23
Cambridge 21
Düsseldorf 21
Woodbridge 20
Milan 18
Beijing 14
Bremen 14
Princeton 14
Kocaeli 13
Boardman 12
Brussels 12
Medford 11
Naples 9
San Mateo 9
Guangzhou 8
Helsinki 8
New York 8
Wilmington 8
Bari 7
Cerami 7
Kunming 6
Roxbury 6
Auburn Hills 5
Lanzhou 5
Des Moines 4
Rockville 4
Ashburn 3
Bologna 3
Catania 3
City of Westminster 3
Genoa 3
Napoli 3
Pontecagnano 3
Shenyang 3
Ancona 2
Angri 2
Barano d'Ischia 2
Bassano del Grappa 2
Campagnano di Roma 2
Castellammare Di Stabia 2
Cesena 2
Cittanova 2
Crema 2
Crispano 2
Dresano 2
Enna 2
Gavardo 2
Haikou 2
Houston 2
Jinan 2
Lecce 2
Legnaro 2
Minturno 2
Mirabella Eclano 2
Montereale Valcellina 2
Mountain View 2
Nanchang 2
Ningbo 2
Padova 2
Palermo 2
Palestrina 2
Pescara 2
Pescia 2
Pozzuoli 2
Racalmuto 2
Rho 2
Rossano 2
Rovigo 2
San Giovanni Teatino 2
San Nicola la Strada 2
San Stino di Livenza 2
Scafati 2
Sestu 2
Trieste 2
Venice 2
Washington 2
Wettingen 2
Agrigento 1
Amsterdam 1
Borås 1
Cameri 1
Campobasso 1
Carlentini 1
Cervere 1
Changchun 1
Colle Di Val D'elsa 1
Copertino 1
Cormano 1
Ercolano 1
Ferrandina 1
Hangzhou 1
Hassan Abdal 1
Hebei 1
Jiaxing 1
Totale 843
Nome #
Analisi delle sottopopolazioni linfocitarie nel trattamento cortisonico 314
Antibodies against food antigens in patients with autistic spectrum disorders. 126
A PILOT STUDY ON LOW-DOSE INTRAVENOUS CICLOPHOSPHAMIDE IN SYSTEMIC SCLEROSIS: EFFICACY, SAFETY AND EFFECTS ON CELLULAR ACTIVATION MARKERS 100
CROSSLINKS PIRIDINICI URINARI IN PAZIENTI AFFETTI DA SCLEROSI SISTEMICA 96
Behavior of soluble intercellular adhesion molecule-1 and endothelial-leukocyte adhesion molecule-1 concentrations in patients with Graves' disease with or without ophthalmopathy and in patients with toxic adenoma 82
Clinical and subclinical atherosclerosis in systemic sclerosis: consequences of previous corticosteroid treatment. 73
Nuove tecnologie CDR (Component Resolved Diagnosis) nell’iter diagnostico di lavoratori ipersuscettibili esposti al lattice: stratificazione del rischio e gestione del giudizio di idoneità 72
ESCREZIONE URINARIA DI PIRIDINOLINE IN PAZIENTI DI SCLEROSI SISTEMICA E LUPUS ERITEMATOSO SISTEMICO 72
CROSSLINKS DEL COLLAGENE NELLE URINE DI PAZIENTI SCLERODERMICI: RISULTATI PRELIMINARI 70
Behavior of sICAM-1 and sELAM-1 concentrations in patients with Graves' disease with or without ophthalmopathy and in patients with toxic adenoma 69
CLINICAL AND SUBCLINICAL ATHEROSCLEROSIS IN SYSTEMIC SCLEROSIS (SSC) PATIENTS 63
Omalizumab for difficult-to-treat dermatological conditions: clinical and immunological features from a retrospective real-life experience 62
Evidence for bone resorption in systemic sclerosis 61
INCREASED LEVES OF URINARY PYRIDINIUM CROSSLINKS OF COLLAGEN IN SYSTEMIC SCLEROSIS. 58
Long-Term Neuromodulatory Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) on Plasmatic Matrix Metalloproteinases (MMPs) Levels and Visuospatial Abilities in Mild Cognitive Impairment (MCI) 31
Sensitization to nsLTP: A Retrospective Study in An Italian Pediatric Population over the Last Decade 1
Totale 1.350
Categoria #
all - tutte 3.744
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.744


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201912 0 0 0 0 0 0 0 0 0 0 6 6
2019/2020154 28 23 16 3 16 6 17 9 13 3 14 6
2020/2021176 16 4 19 11 28 2 21 20 3 32 15 5
2021/2022153 13 1 5 15 34 4 3 5 3 16 10 44
2022/2023359 40 10 13 12 42 24 2 40 152 8 4 12
2023/2024238 26 27 19 30 49 31 22 9 12 13 0 0
Totale 1.350